
The 13 Foods That Could Save Your Kidneys and Your Wallet
Despite being so important, kidney health often does not get the attention it deserves. According to the CDC, more than 1 in 7 adults in the US are living with chronic kidney disease, and many are unaware they have it. That is why daily care and early prevention matter so much.
Looking after your kidneys now can help them keep doing their job for years to come, and a few small, consistent habits can make a big difference.
Don't miss any of CNET's unbiased tech content and lab-based reviews. Add us as a preferred Google source on Chrome.
Fortunately, you don't need to make dramatic lifestyle changes to support kidney health. Incorporating a handful of nutrient-rich superfoods into your regular meals can make a significant difference. These foods help reduce inflammation, support healthy blood flow, and ease the load on your kidneys so they can keep doing their job. If you're looking to give your kidneys the boost they need, these 13 simple additions to your diet are a great way to start.
Your diet and gut health also play a major role in your wellness, especially when it comes to keeping your kidneys healthy. There are 13 superfoods you should keep in mind when considering natural ways to give your kidney health a boost.
Read more: 6 Important Blood Tests You May Need for Your Overall Health
13 superfoods for kidney health
1. Cabbage
This nutrient-dense vegetable is low in both potassium and sodium while packing in fiber, vitamins C and K and more.
Plus, cabbage is versatile. You can use it in salads and slaws, but you can also use it as a wrap for tacos, sandwiches and more.
2. Fatty fish
Fish delivers protein, and when you choose a fatty fish like tuna, salmon or trout, you're also getting omega-3 fatty acids. Omega-3 fats may help reduce fat levels (triglycerides) in the blood and may also lower blood pressure, according to the National Kidney Foundation.
If you have CKD, you may need to keep an eye on the phosphorus and potassium levels of the fish you choose. The National Kidney Foundation has a chart you can use to determine levels in specific types of fish. Although, it's best to consult with your doctor.
Jacobs3. Bell peppers
Like cabbage, bell peppers pack in lots of good nutrients with low levels of potassium. With them, you get vitamins B6, B9, C and K, plus fiber. They deliver antioxidants too.
You can slice them and eat them with dips or roast them and add them to dinner.
4. Cranberries
Cranberries help to prevent urinary tract infections. These usually stay in your bladder, they can travel up to your kidney, making kidney problems worse. Fortunately, regularly consuming cranberries can help you avoid this unwelcome situation.
Plus, cranberries have antioxidants that can help fight inflammation, and they can boost your heart and digestive health. It turns out, these tart berries aren't just for the Thanksgiving table.
5. Blueberries
We've talked about some of the best foods for kidneys, but you can take it a step further. The question is: What foods help repair kidneys? Blueberries deliver.
With high levels of antioxidants and loads of vitamin C and fiber, blueberries are all-around healthy. They can also help to reduce inflammation and support bone health, reversing some of the issues that can come with CKD.
6. Dark, leafy greens
There are plenty of reasons to turn to dark, leafy greens like spinach or kale. They deliver so many nutrients that they can help you get key vitamins and minerals, plus immunity-boosting benefits.
Be advised that greens can come with a decent amount of potassium. If you have CKD, talk to your doctor before adding more of these to your diet.
7. Olive oil
Rich in antioxidants and healthy fatty acids, olive oil can boost your overall wellness. A study from Harvard University found that olive oil may lower cholesterol levels and the risk of cardiovascular disease, dementia and some types of cancer.
Beyond all this, it can help you add flavor to dishes without turning to salt or butter. To get more antioxidants, choose unrefined or cold-pressed olive oil that's virgin or extra virgin.
8. Garlic
Another antioxidant-rich, inflammation-fighting food, garlic also contains a specific compound called allicin. For people with CKD, allicin — an active compound found in garlic — worked just as effectively to help protect kidney health as a prescription drug. If you're looking for the best foods for your kidneys, garlic has to make the list.
Plus, it's an excellent way to add flavor when you're skimping on salt.
9. Onions
From the same family as garlic, onions give you another excellent and salt-free way to add flavor (bonus points if you saute them in olive oil). Onions also deliver important nutrients like vitamins B6 and C, manganese and copper.
They also contain quercetin, a chemical that can help your body fight cancer, and organic sulfur compounds that can reduce your risk of high blood pressure, stroke and heart disease.
Getty Images
10. Cauliflower
Cauliflower brings the crunch, paired with plenty of vitamins C, B6, B9 and K, along with fiber. It also contains compounds your body can use to neutralize certain toxins, a big help when your kidneys aren't doing their best filtration work.
Cauliflower does contain some potassium and phosphorus, though, so while it makes the list of foods good for kidneys, people with CKD may want to moderate their intake.
11. Egg whites
Egg whites are specifically recommended for people with kidney problems. They give you a way to increase your protein levels -- which can be important with later-stage CKD, especially if you're on dialysis.
12. Arugula
Arugula is packed with nutrients your body needs like magnesium, iron, calcium and vitamins A, B9, C and K. Plus, it's antioxidant-rich and has glucosinolates, which can help your body protect itself against a range of cancer types.
You can eat arugula raw (it's a great salad base), but you can also sprinkle it over whatever you're whipping up. It's great on pizzas, in omelets and with pasta, for example.
13. Apples
Apples deliver the cancer-fighting quercetin and fiber that can help to keep your cholesterol and blood sugar at healthy levels. They've got plenty of antioxidants.
Better yet, they're easy to work into your diet. Leave a bowl of apples on your counter and you'll have a kidney-healthy, grab-and-go snack whenever you need one.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
AI in the Mental Health Market 2025-2029: Rise of Hyper-Personalization Drives Revenues at 30.9% CAGR
Key market opportunities in the AI for mental health sector include addressing the mental healthcare gap and enhancing accessibility, leveraging advanced AI tech, and regulatory support Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "AI in Mental Health Market 2025-2029" has been added to offering. The AI in mental health market is poised for significant expansion, with projections indicating an increase of USD 3.13 billion from 2024 to 2029, advancing at a robust CAGR of 30.9% during this period. This comprehensive report provides an in-depth analysis of the market's size, future forecasts, trends, growth drivers, challenges, and a thorough vendor review encompassing approximately 25 vendors. The market's growth is largely fueled by the widening gap in mental healthcare accessibility, alongside rapid advancements in AI and machine learning technologies. Increased investments and evolving regulatory frameworks further bolster the market environment. Key drivers include the surge in hyper-personalization and precision mental healthcare, along with a strategic transition from direct-to-consumer to enterprise models. The incorporation of generative AI to enhance therapeutic interactions is set to amplify market demand. The report encompasses several critical areas such as market sizing, forecasts, and industry analyses. This report combines primary and secondary research, incorporating insights from key industry players, and delivers a sweeping view of market size, regional segmentation, vendor dynamics, and analyses of leading industry enterprises. Both historical and future data are meticulously documented. The AI in mental health market is segmented as follows: By Component Software Services By Technology Natural language processing Deep learning and machine learning Context-aware computing Others By End-user Hospitals and clinics Mental health centers Research institutions Others By Geographical Landscape North America Europe APAC Middle East and Africa South America A thorough vendor analysis aids clients in enhancing their market stance. Detailed examinations of prominent players such as Bark Technologies Inc., BigHealth, Cognoa Inc., Lyra Health Inc., and Spring Health Inc., among others, are provided. This analysis also outlines emerging trends and challenges set to impact market trajectory, equipping companies to capitalize on forthcoming growth opportunities. A selection of companies mentioned in this report includes, but is not limited to: Bark Technologies Inc. BigHealth BioBeats Group Ltd. Cognoa Inc. Infinit Care Inc. Kintsugi Mindful Wellness Inc. Lyra Health Inc. meQuilibrium Inc. Meru Health Inc. Mirror Mental Health LLC. NextGen Healthcare Inc. Quartet Health Inc. SilverCloud Health Ltd. Spring Health Inc. Syra Health Corp. TALKSPACE INC. Woebot Labs Inc. Wysa Inc. Xunfei Healthcare Technology Co. Ltd. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
Trending tickers: Novo Nordisk, Palo Alto Networks, Walmart, Soho House and Nio
Novo Nordisk ( NVO) Copenhagen-listed shares in pharmaceuticals giant Novo Nordisk ( rose nearly 4% on Monday morning, after the company announced that its blockbuster weight-loss drug Wegovy had been approved in the US to treat a form of liver disease. Novo ( said in an announcement on Friday that the US Food and Drug Administration (FDA) had approved Wegovy for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis, in combination with a reduced calorie diet and increased physical activity. Read more: Markets mixed as Zelensky and European leaders head to Washington for war talks The company said that accelerated approval is based on part one of a trial, in which Wegovy, demonstrated a statistically significant and superior improvement in liver fibrosis with no worsening of steatohepatitis, as well as resolution of steatohepatitis with no worsening of liver fibrosis compared to a placebo. The news offers a boost to Novo Nordisk ( which has been facing increasing competition in the weight-loss market, with shares in company currently down nearly 46% year-to-date. Martin Holst Lange, executive vice president, chief scientific officer and head of research and development at Novo ( said: "Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide." Palo Alto Networks (PANW) Shares in Palo Alto Networks (PANW) hovered just above the flatline in pre-market trading on Monday morning, ahead of the US cybersecurity company reporting its fourth quarter earnings later in the day. The company had guided to revenue for the quarter in the range of $2.49bn (£1.83bn) to $2.51bn, which would represent year-over-year growth of between 14% and 15%. Shares in the Palo Alto (PANW) came under pressure following the release of its third quarter earnings in May, as the results failed to impress investors. The cybersecurity company's third quarter revenue came in at $2.3bn, just above expectations, while adjusted earnings per share (EPS) were $0.80. Walmart (WMT) Shares in Walmart (WMT) were also trending on Monday, ahead of the company reporting its second quarter earnings on Thursday. Walmart's results are closely watched by investors as it is the largest retailer in the US, so it is considered to act as a barometer for consumer sentiment. The stock is up nearly 11% year-to-date but edged lower after Walmart (WMT) released a mixed set of first quarter results in May. Walmart (WMT) posted first quarter revenue of $165.5bn, which was up 2.5% from the same period last year, though this missed Wall Street expectations of $166.02bn. Adjusted earnings per share grew 1.7% year over year to $0.61, beating estimates of $0.58. US same-store sales also beat expectations with a 4.5% increase, led by health and wellness, and groceries. Stocks: Create your watchlist and portfolio John David Rainey, chief financial officer of Walmart (WMT), said in the earnings release that the company had decided to hold off on providing a specific range of guidance for operating income growth and earnings per share for the second quarter, given the "dynamic nature of the backdrop". Walmart (WMT) did guide to net sales growth of 3.5% to 4.5% for the quarter, based on the $167.8bn it reported a year ago. AJ Bell's (AJB.L) investment director Russ Mould and head of financial analysis Danni Hewson said that analysts expect a headline figure for net sales of $174bn. "That turns into a consensus analysts' forecasts for [net profit in] the second quarter of $5.8bn, and a headline earnings per share (EPS) figure of $0.72, up from $0.67 a year ago," they said. Soho House (SHCO) Shares in Soho House (SHCO) surged 13% in pre-market trading on Monday, following reports that the members' club was nearing a deal to go private. The Wall Street Journal reported on Sunday that a group of investors led by MCR Hotels was nearing a deal to take Soho House private. Read more: Stocks that are trending today They are reportedly expected to pay around $9 per share for the company's outstanding stock, with the deal valuing the company at $1.8bn. A spokeperson for Soho House (SHCO) had not responded to Yahoo Finance UK's request for comment at the time of writing. Nio ( NIO) Shares in Chinese electric vehicle company Nio ( jumped nearly 7% on Monday, after announcing it expansion into three new markets. Nio ( said in announcement on Monday that it planned to enter Singapore, Uzbekistan and Costa Rica in 2025 and 2026. Chris Chen, head of global business development at Nio ( said: "To accelerate our entry into diverse global markets, Nio is partnering with experienced players who have deep local expertise and extensive distributor networks. "They will help us introduce our high-quality smart electric vehicles to new markets more efficiently." Read more: Bank of England cuts gilt holdings by £32.5bn in second quarter The most popular stocks and funds investors bought in July UK job market continues to weaken as vacancies fall


Medscape
an hour ago
- Medscape
AI Is the New Dr Google — Across the Globe
Patients arriving at appointments with researched information is not new, but artificial intelligence (AI) tools such as ChatGPT are changing the dynamics. Their confident presentation can leave physicians feeling that their expertise is challenged. Kumara Raja Sundar, MD, a family medicine physician at Kaiser Permanente Burien Medical Center in Burien, Washington, highlighted this trend in a recent article published in JAMA . A patient visited Sundar's clinic reporting dizziness and described her symptoms with unusual precision: 'It's not vertigo, but more like a presyncope feeling.' She then suggested that the tilt table test might be useful for diagnosis. Occasionally, patient questions reveal subtle familiarity with medical jargon. This may indicate that they either have relevant training or have studied the subject extensively. Curious, Sundar asked if she worked in the healthcare sector. She replied that she had consulted ChatGPT, which recommended the tilt table test. For years, patients have brought newspaper clippings, internet research, and advice from friends and relatives to consultations. Suggestions shared in WhatsApp groups have become a regular part of clinical discussions. Sundar noted that this particular encounter was different. The patient's tone and level of detail conveyed competence, and the confidence with which she presented the information subtly challenged his clinical judgment and treatment plans. Clinical Practice It is not surprising that large language models (LLMs), such as ChatGPT, are appealing. Recent studies have confirmed their remarkable strengths in logical reasoning and interpersonal communication. However, a direct comparison between LLMs and physicians is unfair. Clinicians often face immense pressure, including constrained consultation times, overflowing inboxes, and a healthcare system that demands productivity and efficiency. Even skilled professionals struggle to perform optimally under adverse conditions. In contrast, generative AI is functionally limitless. This imbalance creates an unrealistic benchmark; however, this is today's reality. Patients want clear answers; more importantly, they want to feel heard, understood, and reassured. Patients value accurate information but also want to feel recognized, reassured, and heard. 'Unfortunately, under the weight of competing demands, which is what often slips for me not just because of systemic constraints but also because I am merely human,' Sundar wrote. Despite the capabilities of generative AI, patients still visit doctors. Though these tools deliver confidently worded suggestions, they inevitably conclude: 'Consult a healthcare professional.' The ultimate responsibility for liability, diagnostics, prescriptions, and sick notes remains with physicians. Patient Interaction In practice, this means dealing with requests, such as a tilt table test for intermittent vertigo, a procedure that is not uncommon but often inappropriate. 'I find myself explaining concepts such as overdiagnosis, false positives, or other risks of unnecessary testing. At best, the patient understands the ideas, which may not resonate when one is experiencing symptoms. At worst, I sound dismissive. There is no function that tells ChatGPT that clinicians lack routine access to tilt-table testing or that echocardiogram appointments are delayed because of staff shortages. I have to carry those constraints into the examination room while still trying to preserve trust,' Sundar emphasized in his article. When I speak with medical students, I notice a different kind of paternalism creeping in. And I have caught it in my inner monologue, even if I do not say it aloud. The old line, 'They probably WebMD'd it and think they have cancer,' has morphed into the newer, just-as-dismissive line, 'They probably ChatGPT'd it and are going to tell us what to order.' It often reflects defensiveness from clinicians rather than genuine engagement and carries an implicit message: We still know the best. 'It is an attitude that risks eroding sacred and fragile trust between clinicians and patients. It reinforces the feeling that we are not 'in it' with our patients and are truly gatekeeping rather than partnering. Ironically, that is often why I hear patients turn to LLMs in the first place,' Sundar concluded . Patient Advocacy One patient said plainly, 'This is how I can advocate for myself better.' The word 'advocate' struck Sundar, capturing the effort required to persuade someone with more authority. Although clinicians still control access to tests, referrals, and treatment plans, the term conveys a sense of preparing for a fight. When patients feel unheard, gathering knowledge becomes a strategy to be taken seriously. In such situations, the usual approach of explaining false-positive test results, overdiagnosis, and test characteristics is often ineffective. From the patient's perspective, this sounds more like, 'I still know more than you, no matter what tool you used, and I'm going to overwhelm you with things you don't understand.' Physician Role The role of physicians is constantly evolving. The transition from physician-as-authority to physician-as-advisor is intensifying. Patients increasingly present with expectations shaped by nonevidence-based sources, often misaligned with the clinical reality. As Sundar observed, 'They arm themselves with knowledge to be heard.' This necessitates a professional duty to respond with understanding rather than resistance. His approach centers on emotional acknowledgment before clinical discussion: 'I say, 'We'll discuss diagnostic options together. But first, I want to express my condolences. I can hardly imagine how you feel. I want to tackle this with you and develop a plan.'' He emphasized, 'This acknowledgment was the real door opener.' Global Trend What began as a US trend observed by Sundar has now spread worldwide, with patients increasingly arriving at consultations armed with medical knowledge from tools like ChatGPT rather than just 'Dr Google.' Clinicians across health systems have reported that digitally informed patients now comprise the majority. In a forum discussion, physicians from various disciplines shared their experiences, highlighting how previously informed patients are now the norm. Inquiries often focus on specific laboratory values, particularly vitamin D or hormone tests. In gynecologic consultations, Internet research on menstrual disorders has become a routine part of patient interactions, with an overwhelming range of answers available online. ' Chanice ,' a Coliquio user who's a gynecologist, shared, 'The answers range from, 'It's normal; it can happen' to 'You won't live long.'' 'It's also common to Google medication side effects, and usually, women end up experiencing pretty much every side effect, even though they didn't have them before.' How should doctors respond to this trend? Opinions are clear: openness, education, and transparency are essential and ideally delivered in a structured manner. 'Get the patients on board; educate them. In writing! Each and every one of them. Once it's put into words, it's no longer a job. Invest time in educating patients to correct misleading promises made by health insurance companies and politicians,' commented another user, Jörg Christian Nast, a specialist in gynecology and obstetrics. The presence of digitally informed patients is increasingly seen not only as a challenge but also as an opportunity. Conversations with these patients can be constructive, but they can also generate unrealistic demands or heated debates. Thus, a professional, calm, and explanatory approach remains crucial, and at times, a dose of humor can help. Another user who specializes in internal medicine added, 'The term 'online consultation' takes on a whole new meaning.' The full forum discussion, 'The Most Frequently Asked 'Dr. Google' Questions,' can be found here. Find out what young physicians think about AI and the evolving doctor-patient relationship in our interview with Christian Becker, MD, MHBA, University Medical Center Göttingen, Göttingen, Germany, and a spokesperson for the Young German Society for Internal Medicine. Read the full interview here.